|2.09||-0.02 / -0.95%|
As of 3:59pm ET
|2.08||-0.01 / -0.48%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 3.50. The median estimate represents a +115.31% increase from the last price of 2.09.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.